Oremex Silver buy Traumtanz
Start price
13.04.23
/
50%
€0.005
Target price
13.04.24
€0.000
Performance (%)
60.00%
End price
18.04.23
€0.008
Summary
This prediction ended on 18.04.23 with a price of €0.008. The BUY prediction by Traumtanz for Oremex Silver saw massive gains of 60.00%. Traumtanz has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Oremex Silver | 0.000% | 0.000% | -33.333% |
iShares Core DAX® | 3.054% | -1.396% | 15.789% |
iShares Nasdaq 100 | 4.389% | -5.391% | 29.906% |
iShares Nikkei 225® | 5.386% | -3.105% | 16.065% |
iShares S&P 500 | 2.955% | -3.011% | 25.903% |
According to Traumtanz what are the pros and cons of Oremex Silver for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Valuable balance sheet
ROE higher than 10% per year
Normal challenges to pay loans and raise capital
Capable Management
Good culture
Innovative
Some uniques
Differentiated customer and product portfolio
Growths faster than the competition
Sustainability is important
Stable Large shareholder and/or long term investor
Medium risks for its business
Top 10 in its market
Small cyclical dependencies
Known brand
Future proof or reliable business model
Cons
Comments by Traumtanz for this prediction
In the thread Oremex Silver diskutieren
Buy mit Kursziel 0,0
In the thread Trading Oremex Silver
Buy beendet
Stopped prediction by Traumtanz for Oremex Silver
Oremex Silver
Start price
Target price
Perf. (%)
€0.005
18.10.23
18.10.23
€0.000
18.10.24
18.10.24
22.22%
24.11.23
24.11.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Oremex Silver
Start price
Target price
Perf. (%)
€0.008
18.04.23
18.04.23
€0.000
18.04.24
18.04.24
-43.75%
18.10.23
18.10.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group